These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 12111921)

  • 1. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes.
    Deeks JJ
    Stat Med; 2002 Jun; 21(11):1575-600. PubMed ID: 12111921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales.
    Warn DE; Thompson SG; Spiegelhalter DJ
    Stat Med; 2002 Jun; 21(11):1601-23. PubMed ID: 12111922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating risk difference from relative association measures in meta-analysis can infrequently pose interpretational challenges.
    Murad MH; Montori VM; Walter SD; Guyatt GH
    J Clin Epidemiol; 2009 Aug; 62(8):865-7. PubMed ID: 19230610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How should meta-regression analyses be undertaken and interpreted?
    Thompson SG; Higgins JP
    Stat Med; 2002 Jun; 21(11):1559-73. PubMed ID: 12111920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.
    Sweeting MJ; Sutton AJ; Lambert PC
    Stat Med; 2004 May; 23(9):1351-75. PubMed ID: 15116347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical evaluation showed that the Copas selection model provided a useful summary in 80% of meta-analyses.
    Carpenter JR; Schwarzer G; Rücker G; Künstler R
    J Clin Epidemiol; 2009 Jun; 62(6):624-631.e4. PubMed ID: 19282148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying the law of iterated logarithm to control type I error in cumulative meta-analysis of binary outcomes.
    Hu M; Cappelleri JC; Lan KK
    Clin Trials; 2007; 4(4):329-40. PubMed ID: 17848494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells.
    Rücker G; Schwarzer G; Carpenter J; Olkin I
    Stat Med; 2009 Feb; 28(5):721-38. PubMed ID: 19072749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis and sensitivity analysis for multi-arm trials with selection bias.
    Chootrakool H; Shi JQ; Yue R
    Stat Med; 2011 May; 30(11):1183-98. PubMed ID: 21538449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of association.
    Jaeschke R; Guyatt G; Shannon H; Walter S; Cook D; Heddle N
    CMAJ; 1995 Feb; 152(3):351-7. PubMed ID: 7828099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size calculations based on slopes and other summary statistics.
    Dawson JD
    Biometrics; 1998 Mar; 54(1):323-30. PubMed ID: 9544525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis of rare and adverse event data.
    Sutton AJ; Cooper NJ; Lambert PC; Jones DR; Abrams KR; Sweeting MJ
    Expert Rev Pharmacoecon Outcomes Res; 2002 Aug; 2(4):367-79. PubMed ID: 19807443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined test procedures in the meta-analysis of controlled clinical trials.
    Knapp G; Hartung J
    Stud Health Technol Inform; 2000; 77():34-8. PubMed ID: 11187570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.
    Furukawa TA; Guyatt GH; Griffith LE
    Int J Epidemiol; 2002 Feb; 31(1):72-6. PubMed ID: 11914297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A logistic model for trend in 2 x 2 x kappa tables with applications to meta-analyses.
    Cook RJ; Walter SD
    Biometrics; 1997 Mar; 53(1):352-7. PubMed ID: 9147599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meta-analysis of therapeutic and preventive clinical trials].
    Lugosi L; Molnár I
    Orv Hetil; 2000 Dec; 141(51):2779-84. PubMed ID: 11196238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.